Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 December 2019 | Story Dr Cindé Greyling | Photo Anja Aucamp
Patents
Dr Mariana Erasmus, SAENSE Platform Manager, says water remediation is vital for both the ecosystem and industries.

KovsieInnovation at the UFS supports innovative research outputs in various ways – one of which is to protect the intellectual property and to register patents where viable. This is in line with KovsieInnovation’s broader aim to create third-stream income for the university. Patent registration is a complex process and the UFS is proud to have the needed expertise to properly facilitate such an endeavour.

The SAENSE Platform

South Africa is a water-scarce country, with many water hungry industries (such as agriculture and mining). “Industrial processes often contaminate water with heavy metals, harmful chemicals, radioactive waste, and even organic sludge,” Dr Mariana Erasmus, SAENSE Platform Manager, explains.

Hence, water remediation is vital for both the ecosystem and industries. One of the key functions of the SAENSE Platform is to offer water-remedial solutions for the (bio)remediation of nitrates, heavy metals, and salts, among others. The platform’s activities and services are supported by undergraduate and postgraduate students and researchers, using Technology Innovation Agency (TIA) funding. TIA is a national public entity that serves as key institutional intervention to bridge the innovation chasm between research and development.

From waste to water

Through the joint effort of two mining companies and the UFS/TIA SAENSE Research Platform, a new treatment for mine drainage (MD) has been developed. This patented B-DAS (Barium – Dispersed Alkaline Substrate) technology effectively treats the major contaminants found in acid, alkaline, or neutral mining wastewater. The aim of the B-DAS system is to provide a passive water-treatment solution with minimum waste production; it can also be a potential pre-treatment for reverse osmosis (RO) to lower the requirements of the membranes and therefore potentially reduce the RO cost.

The success of the patent is that it turns unusable water into water that is fit for agricultural purposes at a reduced cost and increased efficiency.

News Archive

UFS takes a leading role in nuclear medicine and technology
2011-12-06

 
Photo: Dr Glen Taylor

The University of the Free State (UFS) continues to play an active role in the field of Nuclear Medicine and the use of nuclear technology in the biosciences. Dr Glen Taylor, Director of Research Commercialisation and Business Development at the UFS, was recently elected chairperson of the board for the Nuclear Technologies in Medicine and the Biosciences Initiative (NTeMBI).

The UFS is currently one of three centres of excellence in the country identified by the Nuclear Energy Corporation South African (Necsa) to roll out the capacity development programme and increase technology coming from nuclear medicine and technology.
NTeMBI is a national technology platform that is managed by Necsa and supported by the Department of Science and Technology (DST). It functions as a high-level Research, Development and Innovation (RD&I) initiative that will implement new strategic initiatives relating to research and development on nuclear technologies in medicine and the biosciences on a local, regional and international level. 
 
One of the roles Dr Taylor will perform as Chairperson of the board of NTeMBI, is to enhance the exposure of nuclear technology in medicine and the biosciences. Dr Taylor says the aim is to increase the skills base in South Africa. “I realise it is one of the scare skills in the country.” 
 
The UFS already received a significant amount of funding from the grant of R4 million per annum made available from the Department of Science and Technology (DST) to implement NTeMBI projects.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept